Department of Medicine, University of Washington, 1959 NE Pacific Street, Box 356421, Seattle, WA, 98195-6421, USA.
Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
Cancer Causes Control. 2023 Oct;34(10):883-886. doi: 10.1007/s10552-023-01730-x. Epub 2023 Jun 7.
Although racial and ethnic disparities in diagnosis, treatment, and survival have been well documented within the field of hematologic malignancies, very little work has focused on testing interventions that may reduce these disparities. The aim of this commentary is to review prior work in hematologic malignancies and explore new opportunities to develop disparity-reducing interventions by drawing from evidence-based strategies that have been successfully implemented in fields related to hematologic malignancies, including oncology and solid organ transplants. Relevant literature demonstrates that patient navigation and broader insurance coverage have been shown to reduce racial and ethnic disparities among patients with solid malignancies such as colorectal and breast cancer. Evidence-based strategies that might be most applicable to the field of hematologic malignancies include patient navigation and policy changes.
尽管在血液恶性肿瘤领域已经有大量文献记录了诊断、治疗和生存方面的种族和民族差异，但很少有工作关注可能减少这些差异的干预措施的测试。本文的目的是回顾血液恶性肿瘤领域的既往工作，并通过借鉴血液恶性肿瘤相关领域（包括肿瘤学和实体器官移植）成功实施的循证策略，探索开发减少差异的干预措施的新机会。相关文献表明，患者导航和更广泛的保险覆盖已被证明可以减少结直肠癌和乳腺癌等实体恶性肿瘤患者的种族和民族差异。可能最适用于血液恶性肿瘤领域的循证策略包括患者导航和政策改变。
